Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Bromobenzo[b]thiophene-3-carbaldehyde is a chemical compound that belongs to the class of benzothiophene derivatives. It is characterized by its unique chemical structure, which includes a bromo substituent and a thiophene ring, and possesses potential therapeutic and biological activities. 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is recognized for its potential use in the synthesis of pharmaceutical drugs and agrochemicals, as well as in research and development applications within the pharmaceutical and agricultural industries.

16296-72-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 16296-72-3 Structure
  • Basic information

    1. Product Name: 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE
    2. Synonyms: 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE;5-BROMOBENZO[B]THIOPHENE-3-CARBOXALDEHYDE;5-Bromobenzo[b]thiophene-3-carboxaldehyde 97%;5-broMo-1-benzothiophene-3-carbaldehyde
    3. CAS NO:16296-72-3
    4. Molecular Formula: C9H5BrOS
    5. Molecular Weight: 241.1
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 16296-72-3.mol
  • Chemical Properties

    1. Melting Point: 106 °C
    2. Boiling Point: 360.498 °C at 760 mmHg
    3. Flash Point: 171.823 °C
    4. Appearance: /
    5. Density: 1.711 g/cm3
    6. Vapor Pressure: 2.21E-05mmHg at 25°C
    7. Refractive Index: 1.741
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE(16296-72-3)
    12. EPA Substance Registry System: 5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE(16296-72-3)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 22-36
    3. Safety Statements: 26
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16296-72-3(Hazardous Substances Data)

16296-72-3 Usage

Uses

Used in Pharmaceutical Industry:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as a key intermediate in the synthesis of various pharmaceutical drugs due to its potential therapeutic properties. Its unique chemical structure allows it to be a valuable component in the development of new medications with diverse applications.
Used in Agrochemical Industry:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as a precursor in the production of agrochemicals, leveraging its biological activities for applications in pest control and crop protection.
Used in Anticonvulsant Medications:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as an anticonvulsant agent for its potential to treat seizure disorders, offering a new avenue for the development of anti-epileptic drugs.
Used in Antimicrobial Agents:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as an antimicrobial agent, being explored for its ability to combat various types of infections, including bacterial and fungal infections.
Used in Antiparasitic Treatments:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as an antiparasitic agent, showing promise in the treatment of parasitic infections, which could be beneficial in both human and veterinary medicine.
Used in Fluorescent Labeling Reagents:
5-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE is used as a fluorescent labeling reagent for biological and medical imaging applications, taking advantage of its fluorescent properties to enhance visualization in research and diagnostic settings.

Check Digit Verification of cas no

The CAS Registry Mumber 16296-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,2,9 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 16296-72:
(7*1)+(6*6)+(5*2)+(4*9)+(3*6)+(2*7)+(1*2)=123
123 % 10 = 3
So 16296-72-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H5BrOS/c10-7-1-2-9-8(3-7)6(4-11)5-12-9/h1-5H

16296-72-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-1-benzothiophene-3-carbaldehyde

1.2 Other means of identification

Product number -
Other names 5-bromo-benzothiophene-3-carboxaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16296-72-3 SDS

16296-72-3Downstream Products

16296-72-3Relevant articles and documents

USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES AS NEUROPROTECTIVE AGENTS

-

Page/Page column 13-14, (2010/11/28)

The present invention is a methods for neuroprotection, for treating an acute neurodegenerative disorder, for treating a chronic neurodegenerative disorder and/or for preventing neuron death or damage following brain, head and/or spinal cord trauma or inj

Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression

-

Page/Page column 15, (2010/11/28)

The present invention is a method for the treatment of depression comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) as herein defined. The pr

Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder

-

Page/Page column 15, (2010/11/28)

The present invention is a method for the treatment of mania and/or bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) as her

USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN

-

Page/Page column 15, (2010/11/28)

The present invention is a method for the treatment of pain comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) as herein defined. The present

USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION

-

Page/Page column 13, (2010/11/28)

The present invention is a method for the treatment of substance abuse and/or addiction comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) as

Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels

-

Page/Page column 15-16, (2010/11/28)

The present invention is a method for the glucose related disorders and lipid related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel b benzo-heteroaryl sulfamide derivatives of formu

Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis

-

Page/Page column 20, (2010/11/28)

The present invention is a method for treating, preventing, reversing, arresting or inhibiting the occurrence, development and maturation of seizures or seizure-related disorders. More specifically, the present invention is directed to methods for the use

USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE

-

Page/Page column 16, (2010/11/28)

The present invention is a method for the treatment or prevention of migraine comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-heteroaryl sulfamide derivatives of formula (I) as herein def

CO-THERAPY FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS

-

Page/Page column 15, (2010/11/29)

The present invention is directed to a method for the treatment of epilepsy and related disorders comprising administering to a subject in need thereof, co-therapy with a therapeutically effective amount of a benzo-heteroaryl sulfamide derivative as descr

Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents

-

Page/Page column 14, (2008/06/13)

The present invention is directed to novel benzo-fused heteroaryl sulfamide derivatives, pharmaceutical compositions containing them and their use in the treatment of epilepsy and related disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16296-72-3